Eluminex Biosciences Announces First Patient Dosed in the Phase 1b LOTUS Trial of the Novel Trispecific Fusion Antibody EB-105 in Diabetic Macular Edema (DME)

Eluminex Biosciences (Eluminex), a clinical stage, privately held biotechnology company focused on the development of advanced protein therapeutics...

PR NewswireJul 15 11:00 ET

Lotus Resources Director Acquires New Shares

TipRanksJul 14 21:47 ET

Lotus Resources Expands Market Presence

TipRanksJul 12 03:08 ET

Lotus Foods Announces Transformative Investment to Accelerate Shift to a More Regenerative Food System

Lotus Foods, a global pioneer in heirloom, organic and regenerative rice cultivation and a leader in rice-based noodles, today announced an...

PR NewswireJul 10 08:32 ET

CP Axtra's 2Q Core Net Profit May Benefit From Strong Retail Performance -- Market Talk

0742 GMT - CP Axtra's 2Q core net profit is likely to rise by 24.5% on year, driven by robust performance of its Lotus's retail business, CGS International analyst Chaiyatorn Sricharoen says in a

WSJJul 10 03:42 ET

Lotus Technology Strikes Deal for $110 Million Investment

Lotus Technology (LOT) said late Monday it reached a $110 million convertible bond agreement through a private placement from an existing shareholder. The company said the transaction is expected to c

MT NewswiresJun 25 03:56 ET